search
Back to results

Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection

Primary Purpose

HIV Infections

Status
Approved for marketing
Phase
Locations
International
Study Type
Expanded Access
Intervention
Tipranavir
Sponsored by
Boehringer Ingelheim
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an expanded access trial for HIV Infections

Eligibility Criteria

2 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria: Patients aho have a positive serology HIV antibody test confirmed by Western blot, p24 antigen assay, HIV-1 RNA or HIV culture and are highly pre-treated and virus resistant to multiple protease inhibitors.

Sites / Locations

  • 1182.58.31
  • 1182.58.29
  • 1182.58.34 Campus Code 696446
  • 1182.58.42 Synergy Hematology/Oncology
  • 1182.58.43
  • 1182.58.03
  • 1182.58.33 Kaiser Permanente Medical Center, Clinical Trials Unit
  • 1182.58.37 AIDS Health Care Foundation
  • 1182.58.41 Circle Medical, LLC
  • 1182.58.28
  • 1182.58.38
  • 1182.58.40 Drs. Raben and Feldman Research Associates
  • 1182.58.23 Hillsborough County Health Department
  • 1182.58.36 Suite 525
  • 1182.58.08
  • 1182.58.22
  • 1182.58.32
  • 1182.58.15
  • 1182.58.19 Henry Ford Hospital
  • 1182.58.04 Kansas City Free Health Clinic
  • 1182.58.25 Wohl Clinic
  • 1182.58.02 Wellness Center
  • 1182.58.09 Polari Medical Group
  • 1182.58.30
  • 1182.58.06 University of Cincinnati Medical Center, Infectious diseases
  • 1182.58.35
  • 1182.58.14
  • 1182.58.20 University of Pittsburgh
  • 1182.58.01 Boehringer Ingelheim Investigational Site
  • 1182.58.10 Comprehensive Care Center
  • 1182.58.18 University of Texas Southwest Medical Center at Dallas
  • 1182.58.07
  • 1182.58.039 Olmos Park Medical Associates
  • 1182.58.11 Swedish Medical Center
  • 1182.58.44 VW Hospital and Clinics
  • 1182.58.61005 Royal Prince Alfred Hospital
  • 1182.58.61008 St Vincents Hospital
  • 1182.58.61011 St Vincents Hospital
  • 1182.58.61014 St Vincents Hospital
  • 1182.58.61007 407 Doctors Pty Ltd
  • 1182.58.61019 407 Bouke Street
  • 1182.58.61022 Sexual Health Clinic
  • 1182.58.61012 Bigge Park Centre
  • 1182.58.61003 The Prince of Wales Hospital
  • 1182.58.61002 Royal North Shore Hospital
  • 1182.58.61006 Albion Street Clinic
  • 1182.58.61025 Immunology Department
  • 1182.58.61010 Biala Building
  • 1182.58.61009 Level 6
  • 1182.58.61024
  • 1182.58.61016 Princess Alexandra Hospital
  • 1182.58.61020
  • 1182.58.61015 Flinders Medical Centre
  • 1182.58.61001 88 Rathdowne Street Carlton
  • 1182.58.61018 Melbourne Sexual Health Clinic
  • 1182.58.61017 Department of Infectious Diseases
  • 1182.58.61013 Melbourne Sexual Health Clinic
  • 1182.58.61023
  • 1182.58.61021
  • 1182.58.61004 Royal Perth Hospital
  • 1182.58.3201 Boehringer Ingelheim Investigational Site
  • 1182.58.3202 Boehringer Ingelheim Investigational Site
  • 1182.58.3203 Boehringer Ingelheim Investigational Site
  • 1182.58.3204 Boehringer Ingelheim Investigational Site
  • 1182.58.4505 Aarhus Universitetshospital Skejby
  • 1182.58.4501 Rigshospitalet
  • 1182.58.4504 Odense Universitetshospital
  • 1182.58.33029 Hôpital Aix
  • 1182.58.33001 Hôpital Saint Jacques
  • 1182.58.33022 Hôpital Avicenne
  • 1182.58.33020 Hôpital Antoine Beclère
  • 1182.58.33028 Hôpital Louis Mourier
  • 1182.58.33027 Hôpital
  • 1182.58.33034 Hôpital Raymond Poincarré
  • 1182.58.33006 Hôpital Bicêtre
  • 1182.58.33019 Hôpital de l'Hôtel Dieu
  • 1182.58.33031 Hôpital edouard Herriot
  • 1182.58.33009 Hôpital de la Conception
  • 1182.58.33023 Hôpital Sainte Marguerite
  • 1182.58.33030 Hôpital Saint Eloi
  • 1182.58.33032 Hôpital Emile Muller
  • 1182.58.33008 Hôpital Hôtel Dieu
  • 1182.58.33003 Hôpital de l'Archet
  • 1182.58.33013 Hôpital Saint Louis
  • 1182.58.33014 Hôpital Cochin
  • 1182.58.33007 Hôpital Georges Pompidou
  • 1182.58.33005 Hôpital Bichat
  • 1182.58.33017 Hôpital Bichat Claude Bernard
  • 1182.58.33033 Hôpital Tenon
  • 1182.58.33018 Hôpital Saint Antoine
  • 1182.58.33024 Hôpital Necker
  • 1182.58.33035 Hôpital des Abîmes
  • 1182.58.33012 Hôpital Robert Debré
  • 1182.58.33026 Hôpital Ponchaillou
  • 1182.58.33015 Hôpital Civil
  • 1182.58.33025 Hôpital Foch
  • 1182.58.33021 Hôpital Chalucet
  • 1182.58.33002 Hôpital Purpan
  • 1182.58.33016
  • 1182.58.33010 Hôpital Brabois
  • 1182.58.33011 Hôpital Paul Brousse
  • 1182.58.3001
  • 1182.58.44029 Our Lady For Sick Children
  • 1182.58.44016 St James Hospital, Dept of Genito Urinary Medicine
  • 1182.58.3903 Università di Brescia
  • 1182.58.3904 Ospedali Riuniti di Foggia
  • 1182.58.3901 Ospedale Luigi Sacco
  • 1182.58.3902 Ospedale L. Sacco
  • 1182.58.3907 Presidio Ospedaliero di Rimini
  • 1182.58.3905 Presidio Dalmati
  • 1182.58.3906 Ospedale Infantile Regina Margherita
  • 1182.58.3908 Centro Medicina Preventiva
  • 1182.58.35102 Hospital Condes Castro Guimarães
  • 1182.58.27095 Boehringer Ingelheim Investigational Site
  • 1182.58.27098 Boehringer Ingelheim Investigational Site
  • 1182.58.27099 Boehringer Ingelheim Investigational Site
  • 1182.58.27096 Boehringer Ingelheim Investigational Site
  • 1182.58.27097 Boehringer Ingelheim Investigational Site
  • 1182.58.4101 Boehringer Ingelheim Investigational Site
  • 1182.58.4103 Boehringer Ingelheim Investigational Site
  • 1182.58.4104 Boehringer Ingelheim Investigational Site
  • 1182.58.4107 Boehringer Ingelheim Investigational Site
  • 1182.58.4102 Boehringer Ingelheim Investigational Site
  • 1182.58.4105 Boehringer Ingelheim Investigational Site
  • 1182.58.44020 Beckenham Hospital
  • 1182.58.44004 Boehringer Ingelheim Investigational Site
  • 1182.58.44002 Boehringer Ingelheim Investigational Site
  • 1182.58.44025 Boehringer Ingelheim Investigational Site
  • 1182.58.44019 Boehringer Ingelheim Investigational Site
  • 1182.58.44009 Boehringer Ingelheim Investigational Site
  • 1182.58.44023 Boehringer Ingelheim Investigational Site
  • 1182.58.44024 Boehringer Ingelheim Investigational Site
  • 1182.58.44003 Boehringer Ingelheim Investigational Site
  • 1182.58.44005 Boehringer Ingelheim Investigational Site
  • 1182.58.44008 Boehringer Ingelheim Investigational Site
  • 1182.58.44010 Boehringer Ingelheim Investigational Site
  • 1182.58.44014 Boehringer Ingelheim Investigational Site
  • 1182.58.44017 Boehringer Ingelheim Investigational Site
  • 1182.58.44018 Boehringer Ingelheim Investigational Site
  • 1182.58.44026 Boehringer Ingelheim Investigational Site
  • 1182.58.44027 Boehringer Ingelheim Investigational Site
  • 1182.58.44028 Boehringer Ingelheim Investigational Site
  • 1182.58.44031 Boehringer Ingelheim Investigational Site
  • 1182.58.44011 Boehringer Ingelheim Investigational Site
  • 1182.58.44022 Boehringer Ingelheim Investigational Site
  • 1182.58.44030 Boehringer Ingelheim Investigational Site

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
June 10, 2003
Last Updated
November 29, 2016
Sponsor
Boehringer Ingelheim
search

1. Study Identification

Unique Protocol Identification Number
NCT00062660
Brief Title
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Official Title
An Open Label Safety Study to Evaluate the Safety of Tipranavir Plus Ritonavir When Used in Combination With Other Agents for the Treatment of Patients With HIV Infection Who Have Failed and/or Are Intolerant to Combination Antiretroviral Therapy and Have Limited Treatment Options
Study Type
Expanded Access

2. Study Status

Record Verification Date
July 2014
Overall Recruitment Status
Approved for marketing
Study Start Date
May 2003 (undefined)
Primary Completion Date
April 2014 (Actual)
Study Completion Date
April 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Boehringer Ingelheim

4. Oversight

5. Study Description

Brief Summary
To provide early access to tipranavir and evaluate the safety and tolerance of tipranavir combined with low dose of ritonavir in patients with progressive, HIV-1 disease who have failed or are intolerant to currently approved treatments for HIV infection, who are unable to participate in another tipranavir controlled clinical trial and have an urgent need for anti-HIV treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections

7. Study Design

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Tipranavir
Intervention Description
Tipranavir 250 mg soft elastic capsules

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria: Patients aho have a positive serology HIV antibody test confirmed by Western blot, p24 antigen assay, HIV-1 RNA or HIV culture and are highly pre-treated and virus resistant to multiple protease inhibitors.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Organizational Affiliation
Boehringer Ingelheim
Official's Role
Study Chair
Facility Information:
Facility Name
1182.58.31
City
Scottsdale
State/Province
Arizona
Country
United States
Facility Name
1182.58.29
City
Los Angeles
State/Province
California
Country
United States
Facility Name
1182.58.34 Campus Code 696446
City
Los Angeles
State/Province
California
Country
United States
Facility Name
1182.58.42 Synergy Hematology/Oncology
City
Los Angeles
State/Province
California
Country
United States
Facility Name
1182.58.43
City
Los Angeles
State/Province
California
Country
United States
Facility Name
1182.58.03
City
San Francisco
State/Province
California
Country
United States
Facility Name
1182.58.33 Kaiser Permanente Medical Center, Clinical Trials Unit
City
San Francisco
State/Province
California
Country
United States
Facility Name
1182.58.37 AIDS Health Care Foundation
City
Los Angeles
State/Province
Connecticut
Country
United States
Facility Name
1182.58.41 Circle Medical, LLC
City
Norwalk
State/Province
Connecticut
Country
United States
Facility Name
1182.58.28
City
Washington
State/Province
District of Columbia
Country
United States
Facility Name
1182.58.38
City
Miami Beach
State/Province
Florida
Country
United States
Facility Name
1182.58.40 Drs. Raben and Feldman Research Associates
City
South Miami
State/Province
Florida
Country
United States
Facility Name
1182.58.23 Hillsborough County Health Department
City
Tampa
State/Province
Florida
Country
United States
Facility Name
1182.58.36 Suite 525
City
Atlanta
State/Province
Georgia
Country
United States
Facility Name
1182.58.08
City
Honolulu
State/Province
Hawaii
Country
United States
Facility Name
1182.58.22
City
Chicago
State/Province
Illinois
Country
United States
Facility Name
1182.58.32
City
New Orleans
State/Province
Louisiana
Country
United States
Facility Name
1182.58.15
City
Boston
State/Province
Massachusetts
Country
United States
Facility Name
1182.58.19 Henry Ford Hospital
City
Detroit
State/Province
Michigan
Country
United States
Facility Name
1182.58.04 Kansas City Free Health Clinic
City
Kansas City
State/Province
Missouri
Country
United States
Facility Name
1182.58.25 Wohl Clinic
City
St. Louis
State/Province
Missouri
Country
United States
Facility Name
1182.58.02 Wellness Center
City
Las Vegas
State/Province
Nevada
Country
United States
Facility Name
1182.58.09 Polari Medical Group
City
New York
State/Province
New York
Country
United States
Facility Name
1182.58.30
City
Chapel Hill
State/Province
North Carolina
Country
United States
Facility Name
1182.58.06 University of Cincinnati Medical Center, Infectious diseases
City
Cincinnati
State/Province
Ohio
Country
United States
Facility Name
1182.58.35
City
Portland
State/Province
Oregon
Country
United States
Facility Name
1182.58.14
City
Philadelphia
State/Province
Pennsylvania
Country
United States
Facility Name
1182.58.20 University of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
Country
United States
Facility Name
1182.58.01 Boehringer Ingelheim Investigational Site
City
Columbia
State/Province
South Carolina
Country
United States
Facility Name
1182.58.10 Comprehensive Care Center
City
Nashville
State/Province
Tennessee
Country
United States
Facility Name
1182.58.18 University of Texas Southwest Medical Center at Dallas
City
Dallas
State/Province
Texas
Country
United States
Facility Name
1182.58.07
City
Houston
State/Province
Texas
Country
United States
Facility Name
1182.58.039 Olmos Park Medical Associates
City
San Antonio
State/Province
Texas
Country
United States
Facility Name
1182.58.11 Swedish Medical Center
City
Seattle
State/Province
Washington
Country
United States
Facility Name
1182.58.44 VW Hospital and Clinics
City
Madison
State/Province
Wisconsin
Country
United States
Facility Name
1182.58.61005 Royal Prince Alfred Hospital
City
Camperdown
State/Province
New South Wales
Country
Australia
Facility Name
1182.58.61008 St Vincents Hospital
City
Darlinghurst
State/Province
New South Wales
Country
Australia
Facility Name
1182.58.61011 St Vincents Hospital
City
Darlinghurst
State/Province
New South Wales
Country
Australia
Facility Name
1182.58.61014 St Vincents Hospital
City
Darlinghurst
State/Province
New South Wales
Country
Australia
Facility Name
1182.58.61007 407 Doctors Pty Ltd
City
Darlinghusrst
State/Province
New South Wales
Country
Australia
Facility Name
1182.58.61019 407 Bouke Street
City
Darlinghusrst
State/Province
New South Wales
Country
Australia
Facility Name
1182.58.61022 Sexual Health Clinic
City
Kingswood
State/Province
New South Wales
Country
Australia
Facility Name
1182.58.61012 Bigge Park Centre
City
Liverpool
State/Province
New South Wales
Country
Australia
Facility Name
1182.58.61003 The Prince of Wales Hospital
City
Randwick
State/Province
New South Wales
Country
Australia
Facility Name
1182.58.61002 Royal North Shore Hospital
City
St Leonards
State/Province
New South Wales
Country
Australia
Facility Name
1182.58.61006 Albion Street Clinic
City
Surry Hills
State/Province
New South Wales
Country
Australia
Facility Name
1182.58.61025 Immunology Department
City
Westmead
State/Province
New South Wales
Country
Australia
Facility Name
1182.58.61010 Biala Building
City
Brisbane
State/Province
Queensland
Country
Australia
Facility Name
1182.58.61009 Level 6
City
Herston
State/Province
Queensland
Country
Australia
Facility Name
1182.58.61024
City
Nambour
State/Province
Queensland
Country
Australia
Facility Name
1182.58.61016 Princess Alexandra Hospital
City
Woolloongabba
State/Province
Queensland
Country
Australia
Facility Name
1182.58.61020
City
Adelaide
State/Province
South Australia
Country
Australia
Facility Name
1182.58.61015 Flinders Medical Centre
City
Bedford Park
State/Province
South Australia
Country
Australia
Facility Name
1182.58.61001 88 Rathdowne Street Carlton
City
Carlton
State/Province
Victoria
Country
Australia
Facility Name
1182.58.61018 Melbourne Sexual Health Clinic
City
Carlton
State/Province
Victoria
Country
Australia
Facility Name
1182.58.61017 Department of Infectious Diseases
City
Clayton
State/Province
Victoria
Country
Australia
Facility Name
1182.58.61013 Melbourne Sexual Health Clinic
City
Melbourne
State/Province
Victoria
Country
Australia
Facility Name
1182.58.61023
City
Melbourne
State/Province
Victoria
Country
Australia
Facility Name
1182.58.61021
City
South Yarra
State/Province
Victoria
Country
Australia
Facility Name
1182.58.61004 Royal Perth Hospital
City
Perth
State/Province
Western Australia
Country
Australia
Facility Name
1182.58.3201 Boehringer Ingelheim Investigational Site
City
Antwerpen
Country
Belgium
Facility Name
1182.58.3202 Boehringer Ingelheim Investigational Site
City
Bruxelles
Country
Belgium
Facility Name
1182.58.3203 Boehringer Ingelheim Investigational Site
City
Bruxelles
Country
Belgium
Facility Name
1182.58.3204 Boehringer Ingelheim Investigational Site
City
Liège
Country
Belgium
Facility Name
1182.58.4505 Aarhus Universitetshospital Skejby
City
Aarhus C
Country
Denmark
Facility Name
1182.58.4501 Rigshospitalet
City
København Ø
Country
Denmark
Facility Name
1182.58.4504 Odense Universitetshospital
City
Odense C
Country
Denmark
Facility Name
1182.58.33029 Hôpital Aix
City
Aix en Provence cedex 1
Country
France
Facility Name
1182.58.33001 Hôpital Saint Jacques
City
Besançon cedex
Country
France
Facility Name
1182.58.33022 Hôpital Avicenne
City
Bobigny cedex
Country
France
Facility Name
1182.58.33020 Hôpital Antoine Beclère
City
Clamart cedex
Country
France
Facility Name
1182.58.33028 Hôpital Louis Mourier
City
Colombes
Country
France
Facility Name
1182.58.33027 Hôpital
City
Dijon cedex
Country
France
Facility Name
1182.58.33034 Hôpital Raymond Poincarré
City
Garches
Country
France
Facility Name
1182.58.33006 Hôpital Bicêtre
City
Le Kremlin Bicêtre cedex
Country
France
Facility Name
1182.58.33019 Hôpital de l'Hôtel Dieu
City
Lyon cedex 2
Country
France
Facility Name
1182.58.33031 Hôpital edouard Herriot
City
Lyon cedex 3
Country
France
Facility Name
1182.58.33009 Hôpital de la Conception
City
Marseille cedex 5
Country
France
Facility Name
1182.58.33023 Hôpital Sainte Marguerite
City
Marseille cedex 9
Country
France
Facility Name
1182.58.33030 Hôpital Saint Eloi
City
Montpellier
Country
France
Facility Name
1182.58.33032 Hôpital Emile Muller
City
Mulhouse cedex 1
Country
France
Facility Name
1182.58.33008 Hôpital Hôtel Dieu
City
Nantes cedex 1
Country
France
Facility Name
1182.58.33003 Hôpital de l'Archet
City
Nice cedex 3
Country
France
Facility Name
1182.58.33013 Hôpital Saint Louis
City
Paris cedex 10
Country
France
Facility Name
1182.58.33014 Hôpital Cochin
City
Paris cedex 14
Country
France
Facility Name
1182.58.33007 Hôpital Georges Pompidou
City
Paris cedex 15
Country
France
Facility Name
1182.58.33005 Hôpital Bichat
City
Paris cedex 18
Country
France
Facility Name
1182.58.33017 Hôpital Bichat Claude Bernard
City
Paris cedex 18
Country
France
Facility Name
1182.58.33033 Hôpital Tenon
City
Paris cedex 20
Country
France
Facility Name
1182.58.33018 Hôpital Saint Antoine
City
Paris
Country
France
Facility Name
1182.58.33024 Hôpital Necker
City
Paris
Country
France
Facility Name
1182.58.33035 Hôpital des Abîmes
City
Pointe A Pitre
Country
France
Facility Name
1182.58.33012 Hôpital Robert Debré
City
Reims cedex
Country
France
Facility Name
1182.58.33026 Hôpital Ponchaillou
City
Rennes cedex 9
Country
France
Facility Name
1182.58.33015 Hôpital Civil
City
Strasbourg cedex
Country
France
Facility Name
1182.58.33025 Hôpital Foch
City
Suresnes cedex
Country
France
Facility Name
1182.58.33021 Hôpital Chalucet
City
Toulon cedex
Country
France
Facility Name
1182.58.33002 Hôpital Purpan
City
Toulouse cedex 9
Country
France
Facility Name
1182.58.33016
City
Tourcoing
Country
France
Facility Name
1182.58.33010 Hôpital Brabois
City
Vandoeuvre Les Nancy
Country
France
Facility Name
1182.58.33011 Hôpital Paul Brousse
City
Villejuif cedex
Country
France
Facility Name
1182.58.3001
City
Athens
Country
Greece
Facility Name
1182.58.44029 Our Lady For Sick Children
City
Dublin 12
Country
Ireland
Facility Name
1182.58.44016 St James Hospital, Dept of Genito Urinary Medicine
City
Dublin
Country
Ireland
Facility Name
1182.58.3903 Università di Brescia
City
Brescia
Country
Italy
Facility Name
1182.58.3904 Ospedali Riuniti di Foggia
City
Foggia
Country
Italy
Facility Name
1182.58.3901 Ospedale Luigi Sacco
City
Milano
Country
Italy
Facility Name
1182.58.3902 Ospedale L. Sacco
City
Milano
Country
Italy
Facility Name
1182.58.3907 Presidio Ospedaliero di Rimini
City
Rimini
Country
Italy
Facility Name
1182.58.3905 Presidio Dalmati
City
S. Angelo Lodigiano (lo)
Country
Italy
Facility Name
1182.58.3906 Ospedale Infantile Regina Margherita
City
Torino
Country
Italy
Facility Name
1182.58.3908 Centro Medicina Preventiva
City
Verona
Country
Italy
Facility Name
1182.58.35102 Hospital Condes Castro Guimarães
City
Cascais
Country
Portugal
Facility Name
1182.58.27095 Boehringer Ingelheim Investigational Site
City
Cape Town
Country
South Africa
Facility Name
1182.58.27098 Boehringer Ingelheim Investigational Site
City
Cape Town
Country
South Africa
Facility Name
1182.58.27099 Boehringer Ingelheim Investigational Site
City
Cape Town
Country
South Africa
Facility Name
1182.58.27096 Boehringer Ingelheim Investigational Site
City
Durban
Country
South Africa
Facility Name
1182.58.27097 Boehringer Ingelheim Investigational Site
City
Westville, Durban
Country
South Africa
Facility Name
1182.58.4101 Boehringer Ingelheim Investigational Site
City
Basel
Country
Switzerland
Facility Name
1182.58.4103 Boehringer Ingelheim Investigational Site
City
Bern
Country
Switzerland
Facility Name
1182.58.4104 Boehringer Ingelheim Investigational Site
City
Genève
Country
Switzerland
Facility Name
1182.58.4107 Boehringer Ingelheim Investigational Site
City
Genève
Country
Switzerland
Facility Name
1182.58.4102 Boehringer Ingelheim Investigational Site
City
Zürich
Country
Switzerland
Facility Name
1182.58.4105 Boehringer Ingelheim Investigational Site
City
Zürich
Country
Switzerland
Facility Name
1182.58.44020 Beckenham Hospital
City
Beckenham
Country
United Kingdom
Facility Name
1182.58.44004 Boehringer Ingelheim Investigational Site
City
Brighton
Country
United Kingdom
Facility Name
1182.58.44002 Boehringer Ingelheim Investigational Site
City
Cardiff
Country
United Kingdom
Facility Name
1182.58.44025 Boehringer Ingelheim Investigational Site
City
Chertsey
Country
United Kingdom
Facility Name
1182.58.44019 Boehringer Ingelheim Investigational Site
City
Chichester
Country
United Kingdom
Facility Name
1182.58.44009 Boehringer Ingelheim Investigational Site
City
Edinburgh
Country
United Kingdom
Facility Name
1182.58.44023 Boehringer Ingelheim Investigational Site
City
Harrow
Country
United Kingdom
Facility Name
1182.58.44024 Boehringer Ingelheim Investigational Site
City
Leeds
Country
United Kingdom
Facility Name
1182.58.44003 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
1182.58.44005 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
1182.58.44008 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
1182.58.44010 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
1182.58.44014 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
1182.58.44017 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
1182.58.44018 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
1182.58.44026 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
1182.58.44027 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
1182.58.44028 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
1182.58.44031 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
1182.58.44011 Boehringer Ingelheim Investigational Site
City
Peterborough
Country
United Kingdom
Facility Name
1182.58.44022 Boehringer Ingelheim Investigational Site
City
Woolwich
Country
United Kingdom
Facility Name
1182.58.44030 Boehringer Ingelheim Investigational Site
City
Woolwich
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection

We'll reach out to this number within 24 hrs